Bortezomib for the treatment of non-Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bortezomib for the treatment of non-Hodgkin’s lymphoma

Published:2014-09-29 Issue:16 Volume:15 Page:2443-2459
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Bose Prithviraj¹²,Batalo Michael S²,Holkova Beata¹²,Grant Steven¹²³⁴⁵

Affiliation:

1. Virginia Commonwealth University, Massey Cancer Center, Richmond, VA, USA

2. Virginia Commonwealth University, Department of Internal Medicine, Richmond, VA, USA

3. Virginia Commonwealth University, Department of Microbiology and Immunology, Richmond, VA, USA

4. Virginia Commonwealth University, Department of Biochemistry and Molecular Biology, Richmond, VA, USA

5. Virginia Commonwealth University, Department of Human and Molecular Genetics, Richmond, VA, USA

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14656566.2014.965142

Reference131 articles.

1. Protein degradation and protection against misfolded or damaged proteins

2. Proteasome Inhibition As a Novel Therapeutic Target in Human Cancer

3. Aggressive Lymphomas

4. Novel Therapeutics for Aggressive Non-Hodgkin's Lymphoma

5. Management of indolent lymphoma: Where are we now and where are we going

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination treatment of bortezomib and epirubicin increases the expression of TNFRSF10 A/B, and induces TRAIL-mediated cell death in colorectal cancer cells;Biochemical and Biophysical Research Communications;2023-10

2. Oncoviruses: How do they hijack their host and current treatment regimes;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09

3. The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients;Cancers;2022-03-18

4. Non-coding NFKBIZ 3′ UTR mutations promote cell growth and resistance to targeted therapeutics in diffuse large B-cell lymphoma;2021-05-23

5. Carfilzomib in Combination with Bortezomib Enhances Apoptotic Cell Death in B16-F1 Melanoma Cells;Biology;2021-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3